Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical and Vaccine Immunology : CVI|May 22, 2015
A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in HumansOlga Pleguezuelos, Stuart Robinson, Ana Fernández, et al.
Plos One|December 10, 2016
A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge ModelDaniel J Fullen, Bryan Murray, Julie Mori, et al.
Plos One|January 14, 2016
Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge ModelDaniel J Fullen, Nicolas Noulin, Andrew Catchpole, et al.
Plos One|June 10, 2016
Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge ModelDaniel J Fullen, Nicolas Noulin, Andrew Catchpole, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2025
Prophylactic Efficacy of CD388, a Novel Drug-Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a StudyRoxana E Rojas, Ozlem Equils, Jorge Villacian, et al.
Antiviral Therapy|May 30, 2013
Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antiviralsBindiya Bagga, Christopher W Woods, Timothy H Veldman, et al.
American Journal of Respiratory and Critical Care Medicine|July 13, 2010
Viral load drives disease in humans experimentally infected with respiratory syncytial virusJohn P DeVincenzo, Tom Wilkinson, Akshay Vaishnaw, et al.
NEJM Evidence|November 19, 2025
Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza VaccineKelly A Lindert, Alex Mann, Anita Geevarughese, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Effective Aerosol Inoculation of Dose-Escalated Seasonal Influenza H3N2 Virus in Controlled Human Infection ModelNadine Rouphael, Ralph Tanios, Jessica Traenkner, et al.
The Journal of Infectious Diseases|December 16, 2025
Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery SystemsNadine Rouphael, Ralph Tanios, Jessica Traenkner, et al.
Pageof 3